XML 62 R45.htm IDEA: XBRL DOCUMENT v3.10.0.1
Quarterly Financial Data (Unaudited) (Tables)
 12 Months Ended
Sep. 28, 2018
Quarterly Financial Information Disclosure [Abstract]  
Schedule of Quarterly Financial Data
 
 
Fiscal Year 2018
(In millions, except per share amounts)
 
First
Quarter (1)
 
Second
Quarter (2)
 
Third
Quarter (3)
 
Fourth
Quarter (4)
 
Total
Year
Total revenues
 
$
678.5

 
$
729.9

 
$
709.1

 
$
801.6

 
$
2,919.1

Gross margin
 
$
302.8

 
$
318.5

 
$
313.6

 
$
338.7

 
$
1,273.6

Net (loss) earnings from continuing operations
 
$
(112.2
)
 
$
73.2

 
$
72.5

 
$
116.8

 
$
150.3

Net (loss) earnings attributable to Varian
 
$
(112.3
)
 
$
73.2

 
$
72.6

 
$
116.4

 
$
149.9

 
 
 
 
 
 
 
 
 
 
 
Net (loss) earnings per share - basic
 
$
(1.22
)
 
$
0.80

 
$
0.79

 
$
1.27

 
$
1.64

Net (loss) earnings per share - diluted
 
$
(1.22
)
 
$
0.79

 
$
0.79

 
$
1.26

 
$
1.62

 
 
 
 
 
 
 
 
 
 
 
 
 
Fiscal Year 2017
(In millions, except per share amounts)
 
First
Quarter (5)
 
Second
Quarter 
 
Third
Quarter
 
Fourth
Quarter (6)
 
Total
Year
Total revenues
 
$
601.5

 
$
663.2

 
$
632.8

 
$
721.8

 
$
2,619.3

Gross margin
 
$
267.0

 
$
275.6

 
$
265.5

 
$
305.8

 
$
1,113.9

Net earnings from continuing operations
 
$
8.0

 
$
69.5

 
$
69.9

 
$
78.6

 
$
226.0

Net earnings (loss) from discontinued operations
 
$
6.5

 
$
(13.3
)
 
$
—

 
$
—

 
$
(6.8
)
Net earnings attributable to Varian
 
$
13.9

 
$
56.3

 
$
69.7

 
$
78.6

 
$
218.5

Net earnings (loss) per share attributable to Varian – basic:
 
 
 
 
 
 
 
 
 
 
Continuing operations
 
$
0.08

 
$
0.75

 
$
0.76

 
$
0.86

 
$
2.44

Discontinued operations
 
0.07

 
(0.15
)
 
—

 
—

 
(0.08
)
Net earnings (loss) per share - basic
 
$
0.15

 
$
0.60

 
$
0.76

 
$
0.86

 
$
2.36

Net earnings (loss) per share attributable to Varian – diluted:
 
 
 
 
 
 
 
 
 
 
Continuing operations
 
$
0.08

 
$
0.74

 
$
0.75

 
$
0.85

 
$
2.42

Discontinued operations
 
0.07

 
(0.14
)
 
—

 
—

 
(0.07
)
Net earnings (loss) per share - diluted
 
$
0.15

 
$
0.60

 
$
0.75

 
$
0.85

 
$
2.35



(1) 
In the first quarter of fiscal year 2018, net earnings from continuing operations includes a $207.1 million income tax expense related to the tax effect of a change in law related to the Act.
(2) 
In the second quarter of fiscal year 2018, net earnings from continuing operations includes a $16.4 million loss related to hedging the anticipated Australian dollar purchase price for Sirtex and an $11.1 million impairment charge related to our MPTC subordinated loan.
(3) 
In the third quarter of fiscal year 2018, net earnings from continuing operations includes a $13.3 million loss related to hedging the anticipated Australian dollar purchase price of the Sirtex acquisition, an $11.0 million impairment charge related to our MPTC subordinated loan, acquisition costs of $8.4 million, partially offset by the net $9.0 million breakup fee received from Sirtex in connection with the termination of the acquisition.
(4) 
In the fourth quarter of fiscal year 2018, net earnings from continuing operations includes a $8.0 million benefit to income tax expense due to the partial release of a valuation allowance as the result of an acquisition and a $7.1 million benefit to income tax expense related to the Act.
(5) 
In the first quarter of fiscal year 2017, net earnings from continuing operations includes a $38.3 million impairment charge related to its Original CPTC Loans and a $37.8 million allowance for doubtful accounts from CPTC and another proton center.
(6) 
In the fourth quarter of fiscal year 2017, net earnings from continuing operations includes a $13.1 million impairment charge related to its Original CPTC loans.